Beryl Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Beryl Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-63,484	Closed	-$3.05M	–	84
2020 Q1	$3.05M	Buy	+63,484	New	+$2.95M	0.64%	17

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Beryl Capital Management's RARX Position: Q2 2020 in Review

Beryl Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 63,484 shares — an estimated $3.05M sold.

Beryl Capital Management first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $3.05M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Beryl Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Beryl Capital Management sold 63,484 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $3.05M.
Beryl Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Beryl Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.05M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Beryl Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.